BIO-key CEO, Mike DePasquale commented, “We had a broad base of achievements in 2025, the revenue and bottom-line benefits of which will be realized in early 2026 and beyond. In 2025, we completed our ...
GRAPEVINE, Texas & HOLMDEL, N.J., Dec. 08, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) ...
Good morning, everyone. Thank you for standing by, and welcome to BIO-key International's Third Quarter 2025 Conference Call. [Operator Instructions] As a reminder, this conference is being recorded ...
Hosted on MSN
BIO-key anticipates Q1 2026 revenue of approximately $2.2M, targeting breakeven and profitability in 2026
Management gave a near-term revenue target rather than full-year guidance: DePasquale said, “we now anticipate Q1 '26 revenue of approximately $2.2 million,” and said Q1 mix should skew toward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results